the best thing about mesoblast is that when they finally have their breakthrough moment with the fda ( very soon) on any one of their many incredible product candidates (our first fda approval) , it will be followed by many more indications ... they have a stable of winners ready to follow...
and as commercialization becomes a reality the process will improve and gather a rapid momentum
I eagerly look forward to watching mesoblast future unfold , this will be a great Australian story!
by starting more trials we will have continuity of cash flow for a very long time
Ann: Remestemcel Controlled Study in Crohns & Ulcerative Colitis, page-45
-
- There are more pages in this discussion • 58 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.38 |
Change
-0.080(5.50%) |
Mkt cap ! $1.587B | |||
| Open | High | Low | Value | Volume |
| $1.43 | $1.43 | $1.37 | $5.321M | 3.829M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 12214 | $1.38 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.38 | 37660 | 5 |
View Market Depth
| Last trade - 16.10pm 16/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |